Kim et al. analyzed three blood biomarkers as early predictors of CCDS: retinol-binding protein 4 (RBP4), C-X-C-motif chemokine ligand 10 (CXCL10) and NADPH oxidase 4 (NOX4) [34]. This evidence concerns the gene CXCL10 and cerebral creatine deficiency syndrome.